A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Breast Tumors|Breast Cancer|Locally Recurrent and Metastatic Breast Cancer
Interventions: DRUG: AMG 706 placebo|DRUG: Bevacizumab|DRUG: AMG 706|DRUG: Paclitaxel
Sponsor: Amgen